Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients.

Background: The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. This study aimed to define the prognostic value of whole g...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Translational Medicine Vol. 10; no. 1; pp. 185 - 186
Autores principales:	Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Sonego, Paolo, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Formato:	research Journal Article
Publicado:	BioMed Central 2012
Acceso en línea:	Ver este registro en EBSCOhost